Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 795 | 1,497 | 858 | 0 | 0 |
| Gross Profit | 795 | 1,497 | 858 | N/A | N/A |
| Operating Expenses | 14,446 | 14,525 | 13,958 | 14,687 | 13,516 |
| Operating Income | -13,651 | -13,028 | -13,100 | -14,035 | -13,516 |
| Other Income | -1,448 | 441 | 667 | 756 | 32 |
| Pre-tax Income | -15,099 | -12,587 | -12,433 | -13,279 | -13,484 |
| Net Income Continuous | -15,099 | -12,587 | -12,433 | -13,279 | -13,484 |
| Net Income | $-15,099 | $-12,587 | $-12,433 | $-13,279 | $-13,484 |
| EPS Basic Total Ops | -0.55 | -0.62 | -0.62 | 65.72 | -24.19 |
| EPS Basic Continuous Ops | -0.55 | -0.62 | -0.62 | 65.72 | -24.19 |
| EPS Diluted Total Ops | -0.55 | -0.62 | -0.62 | 65.72 | -24.19 |
| EPS Diluted Continuous Ops | -0.55 | -0.62 | -0.62 | 65.72 | -24.19 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.62 | -0.62 | N/A | -24.19 |
| EBITDA(a) | $-13,235 | $-12,598 | $-12,679 | $-14,269 | $-13,098 |